Background Behçet's disease (BD) is a type of vasculitis with distinctive clinical manifestations and multifactorial immunopathogenesis. Association of HLA-B51 (which belongs to the HLA-B5/B35 cross-reacting group) is well recognised as the strongest genetic susceptibility gene so far in BD. Aim The aim of this study is to determine the association of HLA-B51 in our BD cohort in the Midwest region of Ireland. Methods Patients meeting the ISGBD or the ICBD criteria for BD were identified from our institutional database. Medical charts and electronic data were reviewed retrospectively to document the HLA antigen profile of the patients (which were carried out by a same recognised lab in London using Gen-Probe Lifecodes HLA-SSO Typing kits based on Luminex xMAP technology).
Results 22 patients of Irish descent were identified satisfying the diagnosis for BD, and among them 19 patients (6 males, 13 females) were HLA typed. The HLA-B51 antigen was found in only one of the 19 patients (5.3%) with a higher frequency HLA-B*08, B*44 (6 patients each; 31.6%), B*35, B*57 (5 patients each; 26.3%), B*15 (4 patients; 21%) and B*27 (3 patients; 15.8%). We found no association between HLA-B*51 and our Irish cohort of BD patients compared to control. Conclusion The overall frequency of HLA-B51 is not increased in our BD cohort. We acknowledge that the study is subject to several limitations including small sample size. Further study of a larger patient population is needed, which may include combination of BD cohorts throughout the country, which will be important to substantiate, support or refute this finding. -2016-211054.4 Background/objectives Both germ-free condition and administration of oral antibiotics before the onset of arthritis modulate T cell differentiation and attenuate arthritis in mice. However, it is not known whether and how the modulation of intestinal microbiota after the onset of arthritis may influence the disease. Here, we investigated the involvement of commensal intestinal microbiota in the progression of established arthritis in both T cell-dependent and -independent mouse models. Materials and methods Mice with established collagen-induced arthritis (CIA) as well as mice with K/BxN serum-transfer arthritis were treated orally with broad-spectrum antibiotics for one week to partially eliminate intestinal microbiota. 16S rRNA gene high-throughput sequencing was performed to assess the effect of arthritis and antibiotic treatment on the gut microbiota composition. Arthritis was assessed macroscopically and by histology. Differentiation of Th1, Th17 and regulatory T (Treg) cells and production of their prototypic cytokines in intestinal lamina propria and joint-draining lymph nodes were assessed by flow cytometry and Luminex cytokine array. Results Induction of arthritis as such resulted in significant alterations in the gut microbiota. Antibiotic treatment of CIA mice eliminated the majority of the gut microbiota, while the microbiota composition of control mice remained relatively stable. Partial elimination of intestinal microbiota during ongoing CIA specifically suppressed intestinal Th17 cell differentiation without affecting Th1 and Treg cells. Accordingly, production of IL-17, but not IFNg, IL-4 and IL-10, by lamina propria lymphocytes was significantly diminished in antibiotictreated mice. Importantly, elimination of intestinal microbiota resulted in suppressed Th17 cell differentiation in joint-draining lymph nodes and reduced the severity of established CIA. In contrast, antibiotic treatment did not influence disease severity in the T cell-independent K/BxN serum-transfer arthritis. Intriguingly, the abundance of intestinal Th17 cells strongly correlated with the severity of arthritis in the CIA mice. However, elimination of intestinal microbiota after disease onset did not affect the development of anti-collagen type II auto-antibodies. Conclusion These observations suggest that modulation of commensal intestinal microbiota during established arthritis specifically suppresses Th17 differentiation and dampens T cell-mediated arthritic processes. Our study supports the notion that inflammatory signals provided by the gut microbiota continue to promote arthritis after its onset. Background Thiopurine S-methyltransferase is a key enzyme in the metabolization of azathioprine. Reduced activity leads to the accumulation of a toxic metabolite 6-thioguanine. This condition is genetically determined (OMIM *187680) and it occurs in 11% individuals of the Caucasian population. Testing of frequent pathogenic allelic variants before azathioprine therapy is recommended for c.238G>C, c.460G>A, c.626-1G>A and c.719A>G. These variants are most frequent (covers more than 95% cases of reduced activity of TPMT enzyme). Defects in other enzymes involved in azathioprine metabolization are extremely rare.
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DETECTION OF POLYMORPHISMS IN GENES ASSOCIATED WITH AZATHIOPRINE TOXICITY
Hereditary xanthinuria type I is caused by a mutation in the XDH gene (OMIM #278300) and it reduce the activity of xanthine dehydrogenase (XDH). Type II is caused by the mutation in XDH and AOX1 and/or MOCOS gene (OMIM #603592) and lead to inactivity of XDH and aldehyde oxidase (AOX1). Molybdenum cofactor sulfurase (encoded by MOCOS) is essential for activities of XDH and AOX1. In patients with purine enzymopathy the accumulation of 6-thioguanine may also occur.
Materials and methods
We examined the occurrence of pathogenic allelic variants c.238G>C, c.460G>A, c.626-1G>A, c.719A>G by PCR amplification and direct sequencing in 62 individuals.
In addition, we analysed remaining exons of the TPMT gene in four patients with the history of myelotoxicity. In one patient with undetectable serum UA levels we performed highperformance liquid chromatography of urine and we subsequently analysed XDH, AOX1 and MOCOS genes. Results We detected heterozygous allelic variant c.238G>C in one case, heterozygous c.460G>A in six cases, heterozygous c.719A>G in seven cases and homozygous c.719A>G in one case. In one patient with myelotoxicity after azathioprine we discovered an unpublished allelic variant c.85T>C (in silico analysis predicted damaging effect). In one patient we diagnosed xanthinuria type II (xanthine in urine was 137 mmol/ mol creatinine -reference <25) and subsequently analysis identified rare homozygous allelic variant c.362C>T in the MOCOS (in silico analysis predicted damaging effect). Conclusions We detected pathogenic allelic variants in the TPMT in ten patients from 62 individuals. The examination of reduced TPMT enzyme activity should become a standard of care. The relationship between purine enzymopathies and azathioprine metabolization should be further studied. Acknowledgements Supported by Ministry of Health, Czech Republic -conceptual development of research organisation (Institute of Rheumatology -RÚ, 00023728). -2016-211054.6 Background SMOC2, a secreted calcium-binding protein of the BM-40/SPARC family was identified from a chondrogenic extract of articular cartilage and is increased in osteoarthritic cartilage. Previous research demonstrated that Wnt signalling needs to be carefully balanced in cartilage to ensure homeostasis. We evaluated the effect of SMOC2 on in vitro chondrogenesis and its relationship with Wnt signalling. Materials and methods Smoc2 was stably overexpressed or knocked down in ATDC5 cells cultured as micromasses. Impact of SMOC2 on chondrogenesis was evaluated by gene expression analysis of chondrogenic markers (Acan, Col2a1, Col10a1) and by Sirius red, Alcian Blue and Alizarin red staining to evaluate collagens, proteoglycans and mineralization. Femoral head caps of 6 weeks old mice were isolated and stimulated with IL-1b to induce cartilage breakdown. Influence of SMOC2 on cartilage breakdown was evaluated by co-stimulating femoral head caps with recombinant SMOC2 protein. Glycosaminoglycan release in the culture medium was measured by performing a DMMB assay. The influence of SMOC2 on canonical Wnt signalling was assessed by performing a TOP/FOP-flash reporter assay in ATDC5 cells. Human articular chondrocytes were stimulated with Wnt agonist CHIR99021 and recombinant SMOC2 protein to validate the effect of SMOC2 on Wnt signalling. Gene expression of canonical Wnt markers was analysed. Results Gene expression of chondrogenic markers and staining intensity of Alcian blue and Alizarin red in ATDC5 micromasses was strongly reduced in Smoc2 overexpressing cells compared to control. Mice femoral head caps stimulated with recombinant SMOC2 protein showed an increased glycosaminoglycan release after IL-1b treatment in culture medium in comparison to IL-1b stimulation alone. ATDC5 cells stimulated with recombinant SMOC2 exhibit decreased luciferase activity in the Wnt reporter assay. In contrast we observed an increased luciferase activity in ATDC5 cells with transient Smoc2 knockdown. This inhibitory effect of Smoc2 on canonical Wnt signalling was also observed in human articular chondrocytes. Conclusion Smoc2 negatively affects chondrogenic differentiation of precursor cells and increases IL-1b induced breakdown in mice cartilage. Inhibition of canonical Wnt signalling is identified as contributing mechanism.
07.06
SMOC2, A SECRETED CALCIUM-BINDING PROTEIN AFFECTS CHONDROGENIC DIFFERENTIATION OF PRECURSOR CELLS AND HOMEOSTASIS OF CARTILAGE
